We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Drug Cos. Put Off Planning For Generic Competition

Law360 (August 23, 2006, 12:00 AM EDT) -- Even with billions of dollars at stake, pharmaceutical companies are surprisingly slow to prepare for the competitive onslaught brought by generic drugs, a new study concludes.

The study found that a whopping 46% of the surveyed companies only started defending their licensed pharmaceuticals two to four years before patent expiration. 18% launched protection strategies even later, waiting past the two-year countdown to do anything.

The report indicated that in the current legal environment, in which some pharmaceutical companies file abbreviated new drug applications years before patent...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.